Mineralys Therapeutics’ blood pressure drug meets goal in trials

(Reuters) -Mineralys Therapeutics said on Monday its blood pressure drug, lorundrostat, met the main goal in late- and mid- stage trials.

(Reporting by Kamal Choudhury in Bengaluru; Editing by Sriraj Kalluvila)